Total planned funding: $338,277,360
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $53,527,774 |
Zambia | $43,009,305 |
South Africa | $31,477,598 |
Mozambique | $29,832,503 |
Zimbabwe | $29,468,423 |
Asia Regional Program | $24,871,345 |
Tanzania | $19,884,919 |
West Africa Region | $18,148,918 |
Vietnam | $12,010,713 |
Botswana | $10,484,283 |
Burundi | $9,588,040 |
Haiti | $7,848,100 |
Ghana | $6,982,500 |
Côte d'Ivoire | $6,303,831 |
Dominican Republic | $5,598,850 |
Malawi | $5,178,259 |
Democratic Republic of the Congo | $4,933,510 |
India | $4,050,000 |
South Sudan | $2,868,967 |
Rwanda | $2,594,238 |
Eswatini | $2,591,755 |
Indonesia | $2,075,000 |
Lesotho | $1,638,960 |
Namibia | $1,497,275 |
Ethiopia | $1,000,000 |
Kenya | $512,294 |
enumerations.Philippines | $300,000 |
Cambodia | $0 |
Organizational Types
NGO | $338,277,360 |
Program Areas
Prevention | $95,612,792 |
Treatment | $91,080,271 |
Care | $80,138,015 |
Testing | $37,623,943 |
Governance and Systems | $33,660,045 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $81,442,253 |
HVOP: Sexual Prevention: Other Sexual Prevention | $61,180,895 |
HKID: Care: Orphans and Vulnerable Children | $42,355,933 |
HVCT: Testing: HIV Testing and Counseling | $37,623,943 |
HBHC: Care: Adult Care and Support | $25,862,013 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $15,044,775 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $13,778,350 |
OHSS: Health Systems Strengthening | $13,200,649 |
HLAB: Laboratory Infrastructure | $10,307,809 |
HVSI: Strategic Information | $10,151,587 |
PDTX: Treatment: Pediatric Treatment | $9,638,018 |
HVTB: Care: TB/HIV | $6,498,524 |
PDCS: Care: Pediatric Care and Support | $5,421,545 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,087,446 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,309,826 |
HVMS: Management and Operations | $162,294 |
HMIN: Biomedical Prevention: Injection Safety | $155,100 |
HMBL: Biomedical Prevention: Blood Safety | $56,400 |
HTXD: Treatment: ARV Drugs | $0 |